These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30736750)

  • 1. Genomic prediction of tuberculosis drug-resistance: benchmarking existing databases and prediction algorithms.
    Ngo TM; Teo YY
    BMC Bioinformatics; 2019 Feb; 20(1):68. PubMed ID: 30736750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools.
    Schleusener V; Köser CU; Beckert P; Niemann S; Feuerriegel S
    Sci Rep; 2017 Apr; 7():46327. PubMed ID: 28425484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of whole genome sequencing and software tools for drug susceptibility testing of Mycobacterium tuberculosis.
    van Beek J; Haanperä M; Smit PW; Mentula S; Soini H
    Clin Microbiol Infect; 2019 Jan; 25(1):82-86. PubMed ID: 29653190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis: can we use them for clinical decision guidance?
    Macedo R; Nunes A; Portugal I; Duarte S; Vieira L; Gomes JP
    Tuberculosis (Edinb); 2018 May; 110():44-51. PubMed ID: 29779772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GenTB: A user-friendly genome-based predictor for tuberculosis resistance powered by machine learning.
    Gröschel MI; Owens M; Freschi L; Vargas R; Marin MG; Phelan J; Iqbal Z; Dixit A; Farhat MR
    Genome Med; 2021 Aug; 13(1):138. PubMed ID: 34461978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs.
    Phelan JE; O'Sullivan DM; Machado D; Ramos J; Oppong YEA; Campino S; O'Grady J; McNerney R; Hibberd ML; Viveiros M; Huggett JF; Clark TG
    Genome Med; 2019 Jun; 11(1):41. PubMed ID: 31234910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review.
    Papaventsis D; Casali N; Kontsevaya I; Drobniewski F; Cirillo DM; Nikolayevskyy V
    Clin Microbiol Infect; 2017 Feb; 23(2):61-68. PubMed ID: 27665704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance Sniffer: An online tool for prediction of drug resistance patterns of Mycobacterium tuberculosis isolates using next generation sequencing data.
    Muzondiwa D; Mutshembele A; Pierneef RE; Reva ON
    Int J Med Microbiol; 2020 Feb; 310(2):151399. PubMed ID: 31980371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data.
    Feuerriegel S; Schleusener V; Beckert P; Kohl TA; Miotto P; Cirillo DM; Cabibbe AM; Niemann S; Fellenberg K
    J Clin Microbiol; 2015 Jun; 53(6):1908-14. PubMed ID: 25854485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping.
    Quan TP; Bawa Z; Foster D; Walker T; Del Ojo Elias C; Rathod P; ; Iqbal Z; Bradley P; Mowbray J; Walker AS; Crook DW; Wyllie DH; Peto TEA; Smith EG
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29167290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
    Ssengooba W; Meehan CJ; Lukoye D; Kasule GW; Musisi K; Joloba ML; Cobelens FG; de Jong BC
    Infect Genet Evol; 2016 Jun; 40():8-16. PubMed ID: 26917365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QuantTB - a method to classify mixed Mycobacterium tuberculosis infections within whole genome sequencing data.
    Anyansi C; Keo A; Walker BJ; Straub TJ; Manson AL; Earl AM; Abeel T
    BMC Genomics; 2020 Jan; 21(1):80. PubMed ID: 31992201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole genome sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: A potential tool for determining drug-resistance and strain lineage.
    Chatterjee A; Nilgiriwala K; Saranath D; Rodrigues C; Mistry N
    Tuberculosis (Edinb); 2017 Dec; 107():63-72. PubMed ID: 29050774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of WHO catalog of mutations and five WGS analysis tools for drug resistance prediction of
    He G; Zheng Q; Shi J; Wu L; Huang B; Yang Y
    Microbiol Spectr; 2024 Jun; ():e0334123. PubMed ID: 38904370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.
    Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR
    Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
    Imperiale BR; Di Giulio ÁB; Adrián Cataldi A; Morcillo NS
    J Antibiot (Tokyo); 2014 Nov; 67(11):749-54. PubMed ID: 24894185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in drug resistance profiles of Mycobacterium tuberculosis isolates causing pulmonary and extrapulmonary tuberculosis in a medical centre in Taiwan, 2000-2010.
    Lai CC; Liu WL; Tan CK; Huang YC; Chung KP; Lee MR; Hsueh PR
    Int J Antimicrob Agents; 2011 Aug; 38(2):125-9. PubMed ID: 21592735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
    N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong.
    Chan RC; Hui M; Chan EW; Au TK; Chin ML; Yip CK; AuYeang CK; Yeung CY; Kam KM; Yip PC; Cheng AF
    J Antimicrob Chemother; 2007 May; 59(5):866-73. PubMed ID: 17360809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.